Two new ester alkaloids from Portulaca oleracea L. and their bioactivities

References

• Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, et al. 2000. Inflammation and Alzheimer’s disease. Neurobiol Aging. 21(3):383–421.
   PubMed Web of Science ®Google Scholar
• Bona DD, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C, Licastro F, Colonna-Romano G, Lio D, Candore G, et al. 2008. Association between the interleukin-1β polymorphisms and Alzheimer’s disease: a systematic review and meta-analysis. Brain Res Rev. 59(1):155–163.
   PubMedGoogle Scholar
• Coelho DS, Moreno E. 2019. Emerging links between cell competition and Alzheimer’s disease. J Fuel Cell Sci Tech. 132(13)
   Google Scholar
• Cui XY, Ying ZM, Ying XX, Jia LQ, Yang GL. 2021. Three new alkaloids from Portulaca oleracea L. and their bioactivities. Fitoterapia. 154:105020.
   PubMed Web of Science ®Google Scholar
• Duan Y, Ying ZM, He F, Ying XX, Jia LQ, Yang GL. 2021. A new skeleton flavonoid and a new lignan from Portulaca oleracea L. and their activities. Fitoterapia. 153:104993.
   PubMed Web of Science ®Google Scholar
• Duan Y, Ying ZM, Zhang MB, Ying XX, Yang GL. 2022. Two new homoisoflavones from Portulaca oleracea L. and their activities. Nat Prod Res. 36(7):1765–1773.
   PubMed Web of Science ®Google Scholar
• Erkan N. 2012. Antioxidant activity and phenolic compounds of fractions from Portulaca oleracea L. Food Chem. 133(3):775–781.
   Web of Science ®Google Scholar
• Gitter BD, Cox LM, Rydel RE, May PC. 1995. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci USA. 92(23):10738–10741.
   PubMed Web of Science ®Google Scholar
• Griffin WS, Sheng JG, Roberts GW, Mrak RE. 1995. Interleukin-1 expression in different plaque types in Alzheimer’s disease: significance in plaque evolution. J Neuropathol Exp Neurol. 54(2):276–281.
   PubMed Web of Science ®Google Scholar
• Gu YY, Ying ZM, Lan XJ, Ying XX, Yang GL. 2021. Two new esters from the aerial parts of Portulaca oleracea L. and their bioactivities. Phytochem Lett. 44:98–101.
   Web of Science ®Google Scholar
• Guo SN, Li HF, Zhang MB, Lan XJ, Yang Y, Ying XX. 2022. Two new alkaloids with carboxylic acid moieties from Portulaca oleracea and their anti-inflammatory effects. Phytochem Lett. 52:67–71.
   Web of Science ®Google Scholar
• Huang SD, Zhang Y, Cao MM, Di YT, Tang GH, Peng ZG, Jiang JD, He HP, Hao XJ. 2013. Myriberine A, a new alkaloid with an unprecedented heteropentacyclic skeleton from myrioneuron faberi. Org Lett. 15(3):590–593.
   PubMed Web of Science ®Google Scholar
• Jiang MY, Zhang WJ, Yang X, Xiu F, Xu HR, Ying XX, Stien D. 2018. An isoindole alkaloid from Portulaca oleracea L. Nat Prod Res. 32(20):2431–2436.
   PubMed Web of Science ®Google Scholar
• Li C-Y, Meng Y-H, Ying Z-M, Xu N, Hao D, Gao M-Z, Zhang W-J, Xu L, Gao Y-C, Ying X-X. 2016. Three novel alkaloids from Portulaca oleracea L. and their anti-inflammatory effects. J Agric Food Chem. 64(29):5837–5844.
   PubMed Web of Science ®Google Scholar
• Liu PS, Lan XJ, Tao XJ, Tian JY, Ying XX, Stien D. 2022. A new alkaloid and two organic acids from Portulacaoleracea L. and their bioactivities. Nat Prod Res. DOI:10.1080/14786419.2022.2103696
   Web of Science ®Google Scholar
• Liu XL, Wu HB, Tao XJ, Ying XX, Stien D. 2021. Two amide glycosides from Portulaca oleracea L. and its bioactivities. Nat Prod Res. 35(16):2655–2659.
   PubMed Web of Science ®Google Scholar
• Li C, Ying Z, Gao M, Wei W, Hao D, Xu L, Tao X, Zhang W, Ying X, Liu J. 2017. Two new similar alkaloids from Portulaca oleracea L. Nat Prod Res. 31(15):1792–1798.
   PubMed Web of Science ®Google Scholar
• Ma YF, Bao YR, Zhang WJ, Ying XX, Stien D. 2020. Four lignans from Portulaca oleracea L. and its antioxidant activities. Nat Prod Res. 34(16):2276–2282.
   PubMed Web of Science ®Google Scholar
• Ma YF, Li XT, Zhang WJ, Ying XX, Stien D. 2021. A trace alkaloid, oleraisoindole A from Portulaca oleracea L. and its anticholinesterase effect. Nat Prod Res. 35(2):350–353.
   PubMed Web of Science ®Google Scholar
• Mehlhorn G, Hollborn M, Schliebs R. 2000. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci. 18(4-5):423–431.
   PubMed Web of Science ®Google Scholar
• Meng YH, Ying ZM, Xiang Z, Hao D, Zhang WJ, Zheng Y, Gao YC, Ying XX. 2016. The anti-inflammation and pharmacokinetics of a novel alkaloid from Portulaca oleracea L. J Pharm Pharmacol. 68(3):397–405.
   PubMed Web of Science ®Google Scholar
• Mrak RE. 2012. Microglia in Alzheimer brain: a neuropathological perspective. Int J Alzheimers Dis. 2012:165021.
   PubMedGoogle Scholar
• Nayaka HB, Londonkar RL, Umesh MK, Tukappa A. 2014. Antibacterial attributes of apigenin, isolated from Portulaca oleracea L. Int J Mycobact. 2014:1–8.
   Google Scholar
• Olsen T, Cui G, Goll R, Husebekk A, Florholmen J. 2009. Infliximab therapy decreases the levels of TNF-α and IFN-γ mRNA in colonic mucosa of ulcerative colitis. Scand J Gastroentero. 44(6):727–735.
   PubMed Web of Science ®Google Scholar
• Pugliese D, Felice C, Papa A, Gasbarrini A, Rapaccini GL, Guidi L, Armuzzi A. 2017. Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future. Expert Rev Clin Immunol. 13(3):223–233.
   PubMed Web of Science ®Google Scholar
• Rahimi V, Ajam F, Rakhshandeh H, Askari V. 2019. A pharmacological review on Portulaca oleracea L.: focusing on anti-inflammatory, anti-oxidant, immuno-modulatory and antitumor activities. J Pharmacopuncture. 22(1):7–15.
   PubMed Web of Science ®Google Scholar
• Saber S, Youssef ME, Sharaf H, Amin NA, El-Shedody R, Aboutouk FH, El-Galeel Y, El-Hefnawy A, Shabaka D, Khalifa A, et al. 2021. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats. Life Sci. 270:119123.
   PubMed Web of Science ®Google Scholar
• The Pharmacopoeia Commission of PRC. 2020. The pharmacopoeia of the People’s Republic of China (Part 1). Beijing: China Medical Science and Technology Press, p. 51–52.
   Google Scholar
• Tian JY, Ying ZY, Lan XJ, Li YJ, Leng AJ, Ying XX. 2022. Two new metabolites from Portulaca oleracea and their anti-inflammatory activities. Phytochem Lett. 48:114–119.
   Web of Science ®Google Scholar
• Uddin MK, Juraimi AS, Hossain MS, Nahar MA, Ali ME, Rahman MM. 2014. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. Sci World J. 2014:1–6.
   Google Scholar
• Wu P, Guo YG, Jia FY, Wang XL. 2015. The effects of Armillarisin A on serum IL-1β and IL-4 and in treating ulcerative colitis. Cell Biochem Biophys. 72(1):103–106.
   PubMed Web of Science ®Google Scholar
• Xu W, Ying ZM, Tao XJ, Ying XX, Yang GL. 2021. Two new amide alkaloids from Portulaca oleracea L. and their anticholinesterase activities. Nat Prod Res. 35(21):3794–3800.
   PubMed Web of Science ®Google Scholar
• Yang X, Ying ZM, Liu HR, Ying XX Yang GL. 2018a. A new homoisoflavone from Portulaca oleracea L. and its antioxidant activity. Nat Prod Res. 33(24):3500–3506.
   Web of Science ®Google Scholar
• Yang X, Zhang W, Ying X, Stien D. 2018b. New flavonoids from Portulaca oleracea L. and their activities. Fitoterapia. 127:257–262.
   PubMed Web of Science ®Google Scholar
• Zhao R, Gao X, Cai YP, Shao XY, Jia GY, Huang YL, Qin XG, Wang JG, Zheng XL. 2013. Antitumor activity of Portulaca oleracea L. polysaccharides against cervical carcinoma in vitro and in vivo. Carbohydr Polym. 96(2):376–383.
   PubMed Web of Science ®Google Scholar
• Zheng GY, Mo FF, Ling C, Peng H, Gu W, Li M, Chen Z. 2018. Portulaca oleracea L. alleviates liver injury in streptozotocin-induced diabetic mice. Drug Des Devel Ther. 12:47–55.
   PubMed Web of Science ®Google Scholar
• Zhong ZY, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, Wong J, Ding SY, Seki E, Schnabl B, et al. 2018. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 560(7717):198–203.
   PubMed Web of Science ®Google Scholar
• Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D. 2010. Inflammation in Alzheimer’s disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 2(1):1.
   PubMed Web of Science ®Google Scholar